Company: BIAF
Filing Date: 2025-10-09
Form Type: 424B5
Source: 0001493152-25-017591
Chunk: 14

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-10-09
Form: 424B5
Chunk 14
---
us, assuming the purchase of all of the shares of common stock offered hereby.

|                                  |     | Per Share |      |     | Total |              |
|:---------------------------------|:----|:----------|-----:|:----|:------|-------------:|
| Offering price                   |     | $         | 2.50 |     | $     | 1,800,000.00 |
| Placement agent fees             |     | $         | 0.20 |     | $     |   144,000.00 |
| Proceeds, before expenses, to us |     | $         | 2.30 |     | $     | 1,656,000.00 |

In addition, we have agreed to reimburse the actual out-of-pocket expenses of WallachBeth up to $75,000.

We estimate that the total expenses of the offering payable by us, excluding the placement agent fees and expenses, will be approximately $279,000.

WallachBeth may be deemed to be an underwriter within the meaning of Section 2(a)(11) of the Securities Act, and any commissions received by them and any profit realized on the resale of the shares sold by them while acting as principals might be deemed to be underwriting discounts or commissions under the Securities Act. As an underwriter, WallachBeth would be required to comply with the requirements of the Securities Act and the Exchange Act, including, without limitation, Rule 415(a)(4) under the Securities Act and Rule 10b-5 and Regulation M under the Exchange Act. These rules and regulations may limit the timing of purchases and sales of shares by WallachBeth acting as principal. Under these rules and regulations, WallachBeth:

| ● | may                                                                                                                                      
 not engage in any stabilization activity in connection with our securities; and                                                          |
| ● | may                                                                                                                                      
 not bid for or purchase any of our securities or attempt to induce any person to purchase any of our securities, other than as permitted 
 under the Exchange Act, until it has completed its participation in the distribution.                                                    |

| S-8 |

This prospectus supplement and the accompanying prospectus may be made available in electronic format on websites or through other online services maintained by any of WallachBeth or by an affiliate of WallachBeth. Other than this prospectus supplement and the accompanying prospectus, the information on WallachBeth’s website and any information contained in any other website maintained by WallachBeth is not part of this prospectus supplement and the